Children with stunted growth or growth retardation are a frequent problem in pediatric practice. However Stuart & Stevenson (1950) and of Heimendinger (1958a, 1958b), bone age from the atlas
. 11 of these children have pituitary insufficiency of a more or less severe degree. A complete report will be published elsewhere. Height and weight age have been determined from the tables of Stuart & Stevenson (1950) and of Heimendinger (1958a Heimendinger ( , 1958b (Fig. 1) .
The conclusion is that the immediate growth improvement has only been achieved at the expense of a decreased adult size. To summarize: Fig. 1 Constitutional delay of development (Walter Sch.) . Treatment with nandrolone phenyl¬ propionate in a high dose during II/2 years improved growth and bone maturation. Because of the overdosage bone age acceleration markedly exceeds height age acceleration. This results in the following two consequences: 1. Spontaneous puberty, which appears in boys normally at a bone age of about 13 and which was therefore expected in this boy at the age of about 20, began at age 15. 2. The expected adult height decreased from about 180 cm to about 160 cm. The continuing growth acceleration after treatment has been stopped represents the growth spurt of puberty. Same presentation as in fig. 1 . Fig. 10 . Growth and bone maturation in 11 children aged 2 to 13 with pituitary dwarfism before and during treatment with nandrolone phenylpropionate for 11 to 32 months. The slope of the lines (normal = 45°) indicates the velocity of growth and bone maturation before treatment (below the horizontal line) and during treatment (above the horizontal line).
Before treatment growth and bone maturation are slower than normal in most patients (the fast bone maturation in 3 patients is due to thyroid therapy). During therapy they are in most patients faster than before, and often even faster than normal. The therapeutic response of the 3 patients with an operated craniopharyngeoma (marked with a black point) is smaller than in the other patients. fig. 1-3) . However, as soon as human growth hormone was added, an impressive growth spurt was seen. Same presentation as in Fig. 1 Fig. 1 .
The second situation where we could not get a normal growth response is Turner's syndrome. The patient of Fig. 12 is a typical example. The stunted growth of these patients, the lack of a normal growth response to anabolic steroids and the reported finding of an increased growth hormone level in the blood of such patients (Fraccaro et 
